Project description
A fast, inexpensive, and effective proteomics platform could transform personalised medicine
The genome comprises all our genes and our genes are the instructions for the synthesis of all the proteins our body makes (proteome) to carry out its myriad of functions. The human genome codes for about 20 000 different proteins but variations in splicing can tremendously amplify that number. Since they are ubiquitous and play a critical role in disease, proteins and even pieces of them (peptides) are important disease biomarkers and therapy targets. Proteomics has tremendous potential for personalised medicine yet faces challenges in terms of the variety of targets and subsequent specificity, sensitivity, throughput, and cost. ElectroMed is building a platform that could overcome these issues, providing a quantum leap in proteomics for personalised medicine and much more.
Fields of science
- natural scienceschemical scienceselectrochemistry
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
- medical and health scienceshealth sciencespersonalized medicine
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
4362 Esch Sur Alzette
Luxembourg
See on map
Participants (5)
7522 NB Enschede
See on map
G12 8QQ Glasgow
See on map
08002 Barcelona
See on map
1165 Kobenhavn
See on map
75011 Paris
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.